Evidence map›Paper›PMID 31769735›Full record

ArticleEmerging microbes & infections2019

Population dynamics and antigenic drift of

Alba Mir-Cros, Albert Moreno-Mingorance, M Teresa Martín-Gómez, Gema Codina, Thais Cornejo-Sánchez, Mireia Rajadell, Diego Van Esso, Carlos Rodrigo, Magda Campins, Mireia Jané and 3 more

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Vaccine antigen-based genotyping ofMicrobiology spectrum · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Alba Mir-CrosDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4827-9824
Albert Moreno-MingoranceDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3073-5046
M Teresa Martín-GómezDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0001-8119-8749
Gema CodinaDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0002-5313-5086
Thais Cornejo-SánchezDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0002-1350-0413
Mireia RajadellDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Diego Van EssoPrimary Care Health Centre Service 'Muntanya', Catalan Institute of Health, Barcelona, Spain.
Carlos RodrigoDepartment of Paediatrics, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0003-1140-2585
Magda CampinsDepartment of Preventive Medicine and Epidemiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0002-8841-6195
Mireia JanéPublic Health Agency of Catalonia, Barcelona, Spain.
Tomàs PumarolaDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0002-5171-7461
Anna FàbregaDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3866-2291
Juan José González-LópezDepartment of Clinical Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2419-5909
Universitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ESPrimary Health Care · QAPublic Health Agency · GBUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of

Indexed as

Antigenic VariationBacterial Outer Membrane ProteinsBacterial VaccinesBordetella pertussisGenotypeHumansMinisatellite RepeatsPopulation DynamicsSpainVirulence Factors, BordetellaWhooping CoughBacterial Outer Membrane ProteinsBacterial VaccinespertactinVirulence Factors, Bordetellaantigenic variantsMLVApertussis vaccinePFGEWhooping cough

Identifiers

PMID31769735
PMCPMC6882445
OpenAlexW2990421646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.